Drugs / hOKT3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00000936 | Nov 1999 → Mar 2004 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hOKT3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000936 ↗ |
| Action | Inhibit | “T-cell surface glycoprotein CD3 epsilon chain inhibitor” CHEMBL2109253 ↗ |
| Target | CD3E | “T-cell surface glycoprotein CD3 epsilon chain inhibitor” CHEMBL2109253 ↗ |